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C three groups. A group is the degree of coronary stenosis in 50% patients with a total
of 108 cases. B group is the degree of coronary stenosis in patients with a total of 180
cases of 50%-70%. C group is the degree of coronary stenosis in 70% groups of
patients with a total of 224 cases. Statistics of three groups of patients with clinical
data and blood lipid levels, including apolipoprotein A I (apo A I), apolipoprotein B
(apo B), apo A I / apo B analysis of the correlation between degree of the blood lipid
and coronary artery stenosis.
Results: Compared between patients of group A and group B, apolipoprotein B (apo
B) or apo A I / apo B was statistically signiﬁcant (P<0.05). Apolipoprotein A I (apo
A I) is no statistical signiﬁcance between the two groups. The mean level Apo B in B
group increased than in A group, the mean level apo A I / apo B in A group increased
than in B group.
Compared between patients of group A and group C, Apolipoprotein A I (apo apo
A I), apolipoprotein B (apo B) or apo A I / apo B is all statistically signiﬁcant
(P<0.05). The mean level Apo B in C group increased than in A group. The mean
level of apo A Iand apo A I / apo B in A group increase than in the C group;
Compared between patients of group B and group C, Apolipoprotein A I (apo apo
A I), apolipoprotein B (apo B) or apo A I / apo B is all statistically signiﬁcant
(P<0.05). The mean level Apo B in C group increased than in B group. The mean
level apo A I and apo A I / apo B in B group increase than in the C group;
With the severity of coronary stenosis as the dependent variable, apo A I, apo B,
apo A I / apo B as argument, the three are related with the degree of coronary artery
stenosis by the method of multivariate regression analysis. The degree of apo B is
positive correlation with coronary artery stenosis; apo A Iand apo A I / apo B are
negatively related to coronary artery stenosis. By the correlation coefﬁcient, apo A I /
apo B can be found most closely relationship between the degree of coronary stenosis
and the following is apo A I, apo B.
Conclusions: With the severity of coronary stenosis, apo B increases, while apo A
Iand A I / apo B decrease. Apo A I / apo B correlation with coronary artery stenosis is
the most close, followed by apo A I, apo B.
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Objectives: The single nucleotide polymorphisms (SNPs) in the BUD13 homolog
(BUD13) and zinc ﬁnger protein 259 (ZNF259) genes have been associated with one
or more serum lipid parameters in the European populations. However, little is
known about such association in the Chinese populations. The present study was
undertaken to detect the association of 6 BUD13/ZNF259 SNPs and their haplotypes
with hyperlipidemia and to identify the possible gene-gene interactions among these
SNPs.
Methods: Genotyping of BUD13 237+1741T>C (rs10790162), 323-575A>G
(rs17119975), *147C>T (rs11556024), 64G>T (rs35585096) and ZNF259 1093-
336G>A (rs2075290) and *365+359C>G (rs964184) SNPs was performed in 634
hyperlipidemic (TC>5.17 mmol/L and/or TG>1.70 mmol/L) and 547 normolipi-
daemic individuals. Pair-wise linkage disequilibria and haplotype frequencies among
the SNPs were analyzed using Haploview. The association between genotypes and
serum lipid parameters was tested by analysis of covariance. Any variants associated
with the serum lipid parameter at a value of P<0.008 (corresponding to P<0.05 after
adjusting for six independent tests by the Bonferroni correction) were considered
statistically signiﬁcant. Unconditional logistic regression was used to assess the
correlation between the risk of hyperlipidemia and genotypes. The inter-locus
interaction was analyzed by generalized multifactor dimensionality reduction
method. A sign test or a permutation test provides P value for predicting accuracy to
measure the signiﬁcance of an identiﬁed model. The best model is selected as the
combination of marker with maximum cross-validation consistency and minimum
prediction error.
Results: The genotype distribution of all 6 SNPs agreed with Hardy-Weinberg
equilibrium (P>0.05 for all). A signiﬁcant linkage disequilibrium was noted among
the ZNF259 rs2075290, ZNF259 rs964184 and BUD13 rs10790162 SNPs (r2>0.5,
P<0.001). The SNPs of ZNF259 rs2075290, ZNF259 rs964184 and BUD13
rs10790162 were signiﬁcantly associated with serum lipid levels in both hyper-
lipidemic and normolipidaemic populations (P<0.008-0.001). On single locus
analysis, only BUD13 rs10790162 was associated with hyperlipidemia (OR: 2.23,
95% CI 1.05, 4.75, P¼0.015). The haplotype of A-C-A-G-C-C (in the order of the
rs2075290, rs964184, rs10790162, rs17119975, rs11556024 and rs35585096
SNPs) was the commonest haplotype and represented approximately 50% of the
sample. The haplotype of G-G-A-A-C-C, carrying rs964184-G-allele, was associ-
ated with increased risk of hypercholesterolemia (OR: 1.35, 95% CI 1.10, 1.66,
P¼0.005) and hypertriglyceridemia (OR: 1.75, 95% CI 1.39, 2.21, P¼0.000). The
haplotypes of A-C-G-G-C-C and A-C-A-G-T-C, carrying rs964184-C-allele, were
associated with reduced risk of hypercholesterolemia (OR: 0.77, 95% CI 0.61, 0.99,
P¼0.039 and OR: 0.66, 95% CI 0.47, 0.94, P¼0.021, respectively). On multifactor
dimensionality reduction analyses, the two-to-three locus models showed a
signiﬁcant association with hypercholesterolemia and hypertriglyceridemia
(P<0.01-0.001).
Conclusions: The SNPs in the BUD13/ZNF259 in the European populations are also
replicable in the Chinese populations. In addition, inter-locus interactions may existC108 JACC Vol 64/16/Suppl C j October 16among these SNPs. However, further functional studies are still required to clarify
how these SNPs and genes actually affect the serum lipid levels.
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Objectives: To explore the association between postprandial plasma glucose and
autonomic cardiovascular function and cardiac structure and function in elderly
essential hypertensives.
Methods: Oral glucose tolerance test were performed in 257 elderly essential hy-
pertensives who were eligible recruited from health examination center afﬁliated to
Institute of Basic Medicine, Shandong Academy of Medical Sciences. According to
the results of oral glucose tolerance test, participants were divided into three groups,
namely, normal postprandial plasma glucose group, high postprandial plasma glucose
group and diabetes group. All participants were conducted physical examination, 24h
ambulatory electrocardiogram, echocardiogram and blood test. Written informed
consent was obtained from each patient.
Results: In normal postprandial plasma glucose group, high postprandial plasma
glucose group and diabetes group, turbulence onset (TO) was -1.611.74%,
-0.851.27%, and 0.160.91%, respectively; total premature ventricular contraction
of 24-hour was 146.8106.2, 302.2200.6, and 347.7233.6, respectively; turbu-
lence slope (TS) was 10.365.59 mm/RR, 6.922.88 mm/RR, and 4.311.24 mm/
RR, respectively; the standard deviations of all normal RR intervals (SDNN) was
98.5422.83 ms, 87.4024.74 ms, and 79.8520.92 ms, respectively; the end
systolic diameters of left ventricle (LVESD) was 25.362.28 mm, 26.332.07 mm,
and 27.862.13 mm, respectively; fractional shortening of the left ventricular minor
semi axis (LVFS) was 45.184.34%, 43.364.14%, and 39.114.53%, respec-
tively; interventricular septum thickness (IVST) was 9.110.86 mm, 9.571.12
mm, and 9.961.32 mm, respectively; left ventricular posterior wall thickness
(LVPWT) was 9.061.03 mm, 9.171.05 mm, and 9.481.14 mm, respectively;
left ventricular ejection fraction (LVEF) was 64.592.96%, 59.023.12%, and
51.253.04%, respectively; ratio of E/A was 1.140.20, 1.070.23, and
0.930.31, respectively; Tei index was 0.340.09, 0.390.10, and 0.440.10,
respectively. Compared to normal postprandial plasma glucose group, TO, total
premature ventricular contraction of 24-hour, LVESD, LVFS, IVST and Tei index
were markedly elevated, and TS, SDNN, LVEF, and ratio of E/A were signiﬁcantly
decreased in high postprandial plasma glucose group and diabetes group (P<0.01).
TO, LVESD, LVPWT, and Tei index were signiﬁcantly higher, and TS, LVEF, and
ratio of E/A were signiﬁcantly lower in diabetes group compared with high post-
prandial plasma glucose group (P<0.01). Results of correlation analysis and
multivariate linear regression analysis showed that level of postprandial plasma
glucose markedly positively related to TO, total premature ventricular contraction of
24-hour, LVESD, IVST, LVPWT, A peak, and Tei index (r¼0.422, 0.305, 0.418,
0.386, 0.285, 0.242, and 0.440, P<0.01, respectively), and negatively related to TS,
SDNN, LVFS, LVET, E peak and ratio of E/A (r¼-0.426, -0.358, -0.444, -0.326,
-0.284 and -0.403, P<0.01, respectively).
Conclusions: Excessive level of postprandial plasma glucose damage autonomic
cardiovascular function and cardiac structure and function in elderly essential
hypertensives.
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Objectives: To observe the changes of cardiovascular inﬂammatory factors and to
investigate the effect of atorvastatin therapy on inﬂammation in patients with rheu-
matoid arthritis (RA).
Methods: This study included 69 patients with RA, they were randomly divided into
group A (n¼36) and group B (n¼33). All patients received methotrexate (MTX0.2
mg/kg/w, plus prednisone 10 mg /d) and stable doses of NSAID therapy. Group A
plus atorvastatin therapy (20 mg/d) on the basis of the above treatment. Sixteen
healthy individuals of similar age and sex served as controls. Disease activity, lipid
proﬁle, C-creative protein, serum tumor necrosis factor-a (TNF-a), adiponectin were
measured before and after 3 months of treatment.
Results: Atorvastatin combined with MTX therapy signiﬁcantly reduced serum total
cholesterol, low-density lipoprotein cholesterol, and triglycerides, TC/HDL-C, LDL-
C/HDL-C, and increased high-density lipoprotein cholesterol. Disease activity vari-
ables, C-creative protein, TNF-a, and adiponectin were signiﬁcantly improved by the
drug combinations.
Conclusions: Atorvastatin therapy in patients with RA reduced disease activity and
conventional and novel vascular risk factors that promote the atheromatous lesion.
Their possible mechanism may be beniﬁted by the anti-inﬂammatory, the control of
lipid, antioxidative stress, protecting vascular endothelium.–19, 2014 j GW-ICC Abstracts/Epidemiology, Prevention and Control
